Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Sirukumab Promising for RA

Michele B. Kaufman, PharmD, BCGP  |  April 4, 2017

In a clinical trial, RA patients on sirukumab experienced decreased disease activity and improved physical function…

Do You Have What It Takes to Be an Educator?

Karen Appold  |  April 3, 2017

Two rheumatologists share why they became educators, the challenges they face and what keeps them teaching young physicians…

Brain Stimulation May Help with Fibromyalgia

Lara C. Pullen, PhD  |  April 3, 2017

New research examined the use of transcranial direct current stimulation over the dorsolateral prefrontal cortex of the brain to modulate attention in patients with fibromyalgia. The study found that the active current increased heat pain threshold and tolerance. However, a regression analysis showed the effect on executive attention appeared to be independent of the effect on pain…

Recommendations for Sjögren’s Syndrome: How to Address Biologics & Musculoskeletal Pain

Arthritis Care & Research  |  April 2, 2017

The clinical practice guidelines for managing Sjögren’s syndrome, developed by the Sjögren’s Syndrome Foundation with the ACR, were designed to improve quality and consistency of care. In total, 19 recommendations were agreed on, which include managing the rheumatic and systemic aspects of the disease. Recommendations include a decision tree for the use of DMARDs for inflammatory musculoskeletal pain, use of self-care measures and exercise to reduce fatigue, and the use of rituximab in selected clinical settings for oral and ocular dryness…

Kansas Governor Sam Brownback Vetoes Medicaid Expansion Bill

Timothy Mclaughlin  |  March 31, 2017

(Reuters)—The governor of Kansas on Thursday vetoed a bill expanding eligibility for Medicaid under the federal Affordable Care Act (ACA), saying he could not support legislation that provided tax dollars to Planned Parenthood and failed to meet other requirements he has laid out for expansion. State lawmakers in the Republican-controlled senate voted in favor of…

Insurance Subcommittee Responds to Health Plan Complaints

From the College  |  March 31, 2017

The ACR Insurance Subcommittee (ISC) regularly engages with insurance companies to discuss concerns raised by ACR members and advocate for appropriate coverage and payment policies. The ISC has gotten off to a busy start in 2017, working on a variety of patient access and reimbursement issues. Two recent issues the ISC has taken action on…

U.S. Senator Launches Probe into 5 Top Opioid Drugmakers

Reuters Staff   |  March 29, 2017

(Reuters)—U.S. Democratic Senator Claire McCaskill sought on Tuesday details from the nation’s top opioid drugmakers on their sales and marketing practices, as lawmakers step up efforts to tackle the country’s deadly opioid crisis. The Missouri senator’s investigation comes amid an epidemic of opioid addiction, with 91 Americans dying everyday as a result of overdose, according…

Kansas Passes Medicaid Expansion Bill Despite Governor’s Objection

Reuters Staff  |  March 29, 2017

(Reuters)—The Kansas Senate gave final approval on Tuesday to a bill expanding eligibility for Medicaid under the federal Affordable Care Act (ACA) even though the measure faces a likely veto by Republican Governor Sam Brownback. The 25-14 Senate vote followed the House’s 81-44 passage of the bill last month, with the vote totals falling short…

Immune-Related Adverse Events with Use of Checkpoint Inhibitors for Immunotherapy of Cancer

Arthritis & Rheumatology  |  March 29, 2017

Introduction: Major advances in the past two decades have enhanced our understanding of the complex interactions between the immune system and cancer cells and their environment. Genetic and epigenetic alterations in tumor cells result in the expression of diverse antigens that can elicit an immune response, primarily mediated by T cells. Immune responses are regulated…

Would Legalizing Medical Marijuana Help Curb the Opioid Epidemic?

Ronnie Cohen  |  March 28, 2017

(Reuters Health)—In states that legalized medical marijuana, U.S. hospitals failed to see a predicted influx of pot smokers, but in an unexpected twist, they treated far fewer opioid users, a new study shows. Hospitalization rates for opioid painkiller dependence and abuse dropped on average 23% in states after marijuana was permitted for medicinal purposes, the…

  • « Previous Page
  • 1
  • …
  • 211
  • 212
  • 213
  • 214
  • 215
  • …
  • 317
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences